Neogenomics, inc. (NEO)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues [Abstract]
Total revenue

106,030

106,868

104,672

101,713

95,577

76,476

69,096

67,746

63,423

61,422

59,137

62,264

57,428

48,214

60,761

63,129

59,704

27,280

25,126

24,370

23,026

25,000

23,217

20,670

18,182

18,323

16,884

15,603

15,657

14,894

14,202

15,611

15,160

12,893

11,320

10,466

8,805

8,708

8,490

COST OF REVENUE

59,661

56,945

53,840

52,747

48,462

39,365

36,775

37,216

36,120

34,661

34,242

34,912

34,480

33,233

33,416

34,524

32,531

15,052

13,955

13,557

13,482

13,528

12,923

10,431

9,473

9,160

8,713

8,446

8,411

8,461

8,310

8,244

8,016

7,060

6,246

5,810

4,940

4,818

4,575

Pharma Services & research revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

251

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

BioPharma & research revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

315

187

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

GROSS PROFIT

46,369

49,923

50,832

48,966

47,115

37,111

32,321

30,530

27,303

26,761

24,895

27,352

22,948

14,981

27,345

28,605

27,173

12,228

11,171

10,813

9,544

11,472

10,294

10,239

8,709

9,163

8,171

7,157

7,246

6,433

5,892

7,367

7,144

5,833

5,074

4,656

3,865

3,890

3,915

Operating expenses:
General and administrative

36,344

33,220

33,054

29,577

32,142

25,717

21,055

20,983

17,067

16,641

18,268

18,432

17,018

8,117

19,025

18,779

18,005

12,596

7,438

7,075

6,522

6,514

6,370

5,870

5,054

4,823

4,335

4,064

4,175

4,098

3,929

4,066

3,750

3,531

3,182

2,914

2,704

2,919

2,769

Research and development

2,060

2,080

2,611

2,587

1,209

526

446

1,073

956

557

1,270

947

862

930

967

1,306

1,446

1,855

871

803

669

414

1,014

633

628

649

340

616

835

448

808

528

497

127

125

172

119

-

-

Sales and marketing

13,258

12,302

11,508

12,324

11,216

8,047

6,900

7,680

6,775

5,858

6,363

6,132

5,648

5,825

5,958

6,327

5,800

2,993

2,748

2,907

2,914

3,225

2,983

3,158

2,633

2,487

2,336

1,972

1,931

1,692

1,839

1,934

2,036

1,801

1,725

1,684

1,753

1,983

1,943

Loss on sale of business

-

-

-

-

-

-

-

-

-

-

-1,058

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

51,662

47,602

47,173

44,488

44,567

34,290

28,401

29,736

24,798

23,056

26,959

25,511

23,528

18,336

25,950

26,412

25,251

17,444

11,057

10,785

10,105

10,153

10,367

9,661

8,315

7,959

7,011

6,652

6,941

6,238

6,576

6,528

6,283

5,459

5,032

4,770

4,576

4,902

4,712

(LOSS) INCOME FROM OPERATIONS

-5,293

2,321

3,659

4,478

2,548

2,821

3,920

794

2,505

3,705

-2,064

1,841

-580

-3,355

1,395

2,193

1,922

-5,216

114

28

-561

1,319

-73

578

394

1,204

1,160

505

305

195

-684

839

861

374

42

-114

-711

-1,012

-797

Interest expense and debt termination fees, net

819

380

203

1,304

1,826

1,464

1,873

1,407

1,486

9,713

-1,398

-1,411

-1,364

14,507

-1,468

-1,448

-1,593

1,087

-239

-189

195

-

-

-

-

-

-

-

285

-

291

288

258

222

185

179

182

-

-

Other (income) expense

223

494

35

10

-5,169

45

30

-124

63

-12

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

0

-1,018

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

INTEREST AND OTHER EXPENSE  NET

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-218

-253

-265

-

-231

-232

-

-

-

-

-

-

-

-

-

-186

-181

Loss before taxes

-5,889

2,435

3,491

2,166

-4,447

1,402

2,077

-737

1,082

2,326

-3,462

430

-1,944

-8,844

-73

745

329

-3,447

-125

-161

-756

1,126

-291

325

129

963

929

273

20

-114

-975

551

603

152

-143

-293

-893

-

-

Income tax expense (benefit)

1,089

-3,861

1,348

175

-2,023

1,049

54

-357

438

-2,224

802

-53

-779

-2,201

-6

332

174

-1,974

0

15

5

79

0

51

27

106

29

0

17

-

-

-

-

0

0

0

0

-

-

NET LOSS

-6,978

6,296

2,143

1,991

-2,424

353

2,023

-380

644

4,550

-4,264

483

-1,165

-6,643

-67

413

155

-1,473

-125

-176

-761

1,047

-291

274

102

857

900

273

3

-114

-975

551

603

152

-143

-293

-893

-1,198

-978

Deemed dividends on preferred stock and amortization of beneficial conversion feature

-

-

0

0

-

1,853

0

2,771

1,003

7,812

912

929

894

12,491

1,840

1,840

1,840

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of preferred stock beneficial conversion feature

-

-

-

-

-

-

-

-

1,853

-

1,739

1,710

1,672

-4,518

3,727

3,727

3,727

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on redemption of preferred stock

-

-

0

0

-

-

0

9,075

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS

-

-

2,143

1,991

-

353

2,023

5,924

-2,212

1,859

-6,915

-2,156

-3,731

-14,616

-5,634

-5,154

-5,412

-1,595

-125

-176

-761

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NET LOSS PER SHARE
Basic (in dollars per share)

-0.07

0.07

0.02

0.02

-0.03

0.01

0.02

0.07

-0.03

0.03

-0.09

-0.03

-0.05

-0.19

-0.07

-0.07

-0.07

-

-

-

-

-

-

-

-

-

0.02

0.01

-

-

-

-

-

-

-

-

-

-

-

Diluted (in dollars per share)

-0.07

0.07

0.02

0.02

-0.03

0.01

0.02

0.07

-0.03

0.03

-0.09

-0.03

-0.05

-0.19

-0.07

-0.07

-0.07

-

-

-

-

-

-

-

-

-

0.02

0.01

-

-

-

-

-

-

-

-

-

-

-

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.00

-0.01

-

-0.01

0.01

0.00

-

-

-

0.00

0.00

-0.02

0.01

0.01

0.00

0.00

-0.01

-0.02

-

-

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.00

-0.01

-

-0.01

0.01

0.00

-

-

-

0.00

0.00

-0.02

0.01

0.01

0.00

0.00

-0.01

-0.02

-

-

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
Basic (in shares)

104,484

104,944

103,899

98,297

94,740

93,695

87,253

81,017

80,507

80,024

79,617

79,413

78,650

78,507

78,145

77,448

76,068

60,865

60,537

60,425

60,277

60,321

54,444

49,890

49,277

49,062

48,933

48,793

46,264

134,843

45,175

44

44

43,337

43,104

42,857

41,734

-

-

Diluted (in shares)

104,484

109,504

107,880

102,336

94,740

104,698

90,899

90,168

80,507

80,024

79,617

79,413

78,650

78,507

78,145

77,448

76,068

60,865

60,537

60,425

60,277

62,418

54,444

53,733

53,469

53,260

53,173

53,744

50,923

149,589

45,175

47

47

43,337

43,104

42,857

41,734

-

-

NET LOSS PER SHARE - Basic and Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.03

-0.03

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - Basic and Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

37,376

37,307

Clinical Services
Total revenue

92,982

93,404

92,565

88,982

86,210

65,913

59,449

59,540

56,971

53,456

51,187

55,547

52,907

43,482

55,739

56,316

54,622

26,826

24,875

24,055

22,839

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

COST OF REVENUE

-

-

-

-

-

-

-

-

-

-

30,150

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

GROSS PROFIT

44,059

-

45,039

42,602

43,559

-

27,940

27,505

25,929

-

21,037

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Pharma Services
Total revenue

13,048

13,464

12,107

12,731

9,367

10,563

9,647

8,206

6,452

7,966

7,950

6,717

4,521

4,732

5,022

6,813

5,082

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

COST OF REVENUE

-

-

-

-

-

-

-

-

-

-

4,092

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

GROSS PROFIT

2,310

-

5,793

6,364

3,556

-

4,381

3,025

1,374

-

3,858

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-